Robinhood stock gets another Wall Street push — but can HOOD really make investors millionaires?

Robinhood stock gets another Wall Street push — but can HOOD really make investors millionaires?

New York, January 20, 2026, 07:22 EST

  • Robinhood shares slip in premarket trading as questions resurface over its lofty valuation
  • Recent commentary points to reliance on trading surges, with no real test from a bear market yet
  • Bulls are betting on prediction markets and fresh products to fuel the next wave of growth

Robinhood Markets (HOOD) dipped about 1.4% in premarket trading Tuesday, slipping to $108.74. That values the brokerage app close to a $127 billion market cap. The price-to-earnings ratio hovers near 58, indicating investors are shelling out a steep premium for the company’s earnings.

The dip did little to settle the debate around Robinhood’s stock: is there more upside, or have the shares already outpaced the company’s fundamentals?

This matters because Robinhood wants to prove it can grow no matter how markets perform in 2026—not just when retail trading surges. The stock’s current valuation makes that challenge even bigger.

A column published Monday flagged Robinhood’s brokerage arm as exposed, caught between low barriers to entry and bigger rivals with deeper pockets. It pointed out that a significant share of the company’s revenue still depends on routing customer orders to market makers—a practice known as payment for order flow. While the article recognized Robinhood’s expansions into banking products and event-driven trading, it slammed the shares as expensive. Analysts forecast roughly 22% revenue growth by 2026, yet the stock trades near 50 times the anticipated $2.44 earnings per share. 1

On Jan. 18, a report highlighted Robinhood’s shares have jumped 1,100% over the last three years but warned the stock looks “priced for perfection,” sporting a P/E ratio close to 49 versus the tech sector’s average of 44. The piece also noted Robinhood hasn’t faced a bear market—a prolonged slump—since going public in 2021, a period when trading volumes usually fall. 2

Bulls remain anchored to sell-side research for backing. A Jan. 19 recap spotlighted earlier calls from Piper Sandler and Mizuho, which set price targets at $155 and $172, respectively. Those analysts highlight Robinhood’s strong grip on younger U.S. investors and suggest its prediction markets might outperform certain crypto brokers. 3

Robinhood has been carving out its space in that financial niche. “We as a firm are going to be looking to see if there is an acquisition that’s available,” JB Mackenzie, vice president and general manager at Robinhood, told Reuters in October. The company is zeroing in on event contracts — bets that pay off if specific outcomes happen — with Piper Sandler estimating Robinhood’s revenue run-rate from this area at more than $200 million as of September. 4

But the product pulls Robinhood into a tougher policy and competitive fight. “There are a plethora of competitors. But with us being early to market, we’ve been able to fine-tune our product,” Adam Hickerson, senior director of the company’s futures business, told Reuters last month, as some state regulators called for tighter oversight of event contracts. Critics say these contracts resemble sports betting and might encourage riskier trades among retail investors. 5

Competition is already baked in. Charles Schwab, a traditional broker, matches low commissions, while Kalshi plays a dual role as both partner and competitor in event markets. Coinbase remains a key player in crypto trading.

Investors are focused on one key question: will Robinhood keep expanding its user base and revenue if market activity cools? And can new products ease its dependence on trading surges to boost profits? Until the numbers show those shifts, the “millionaire-maker” label carries both attention and skepticism.

Stock Market Today

Reckitt share price ends week near a one-year high as RKT investors eye special dividend and March results

Reckitt share price ends week near a one-year high as RKT investors eye special dividend and March results

7 February 2026
London, Feb 7, 2026, 08:16 GMT — Market closed. Reckitt Benckiser Group (RKT.L) shares ended Friday at 6,400 pence, down 0.2%, after touching a one-year high of 6,432 pence. About 2.6 million shares changed hands. 1 The stock is now trading through the tail-end of a chunky one-off cash return. Reckitt has set a 235 pence-a-share special dividend for Feb. 20 and is pairing it with a 24-for-25 share consolidation to keep the quoted share price and per-share metrics broadly comparable after the payout. 2 In the wider market, Britain’s FTSE 100 finished Friday up 0.6%, with gains in heavyweight
GSK share price set for Monday watch after EU clears Nucala COPD use

GSK share price set for Monday watch after EU clears Nucala COPD use

7 February 2026
GSK shares closed Friday up 0.83% at a 52-week high after the EU approved Nucala for certain uncontrolled COPD patients. Insider filings showed chairman Jonathan Symonds bought 2,500 shares while executive David Redfern sold 100,000. The FTSE 100 rose 0.6%. Broker ratings on GSK remained mixed.
Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

7 February 2026
Aye Finance raised Rs 454.5 crore from 19 anchor investors ahead of its Feb 9 IPO, pricing shares at the top of a Rs 122–129 range. The company’s profit fell 40% to Rs 64.3 crore in the six months to September as bad loans rose to 4.85%. The IPO values Aye at about Rs 3,200 crore, below its last private round. Major investors include Nippon Life India and Goldman Sachs funds.
BAT share price closes near 52-week high as buyback rolls on ahead of results week

BAT share price closes near 52-week high as buyback rolls on ahead of results week

7 February 2026
British American Tobacco shares closed up 1.2% at 4,609 pence Friday, near a 52-week high. The company disclosed further share buybacks and management share purchases ahead of its Feb. 12 full-year results. BAT bought 121,668 shares for cancellation on Feb. 5. Investors await updates on nicotine alternatives and cash returns.
CoreWeave stock drops premarket as AI cloud bulls run into debt nerves
Previous Story

CoreWeave stock drops premarket as AI cloud bulls run into debt nerves

ImmunityBio stock jumps before the open after FDA outlines next step for ANKTIVA filing
Next Story

ImmunityBio stock jumps before the open after FDA outlines next step for ANKTIVA filing

Go toTop